Skip to main content
SpringerLink
Log in

Editor’s introduction

Measles and poliomyelitis: vaccines, immunization, and control

  • Chapter
Measles and Poliomyelitis

Abstract

Measles and poliomyelitis happen to be two well known viral diseases which inconceivably remain yet to be fully eradicated worldwide. Similarities exist in their both, being preventable with highly effective and safe vaccines, and in causing acute seif limiting infections exclusively in humans. Despite their successful control in the industrialized countries of the world, their threat as two major diseases of the developing world still remains. Immuni-zation programmes proved to be perhaps more a successful experience with poliomyelitis than measles in Controlling and eliminating infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Henderson RH ,Keja J, Hayden G (1988) Immunizing the children of the world: Progress and prospects. Bull WHO 66: 535–543

    PubMed  CAS  Google Scholar 

  2. Clements CJ, Strassburg M, Cutts FT, Milstein J, Torel C (1992) Global control of measles. In: Kurstak E (ed) Control of Virus Diseases, Sec. Edition, 179–211, Dekker: New York, p 179–211

    Google Scholar 

  3. Schlenker TL, Bain C, Boughman AL, Hadler SC (1992) Measles herd immunity. The association of attack rates with immunization rates in pre-school children. JAMA 267 (6): 823–826

    Article  PubMed  CAS  Google Scholar 

  4. Preblud SR, Katz SL (1988) Measles vaccine. In: Plotkin SA, Mortimer EA (Eds) Vaccines, Saunders, Philadelphia, p 182–222

    Google Scholar 

  5. Taylor WR, Mambu RK, Ma-Disu M, Weinman JM (1988) Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol 127: 788–794

    PubMed  CAS  Google Scholar 

  6. Aaby P, Samb B, Simondon F, Whittle H, Sec AM, Knudsen K, Bennett J, Markowitz L, Rhoses P (1991) Child mortality after high titre measles vaccines in Senegal, the complete data set. Lancet 338:1518

    Article  PubMed  CAS  Google Scholar 

  7. Whittle PF, Mann G, Eckles M (1988) Effect of dose and strain of vaccine on success of measles vaccination of infants aged 4–5 months. Lancet i: 963–966

    Article  Google Scholar 

  8. WHO/EPI (1990) Measles immunization before 9 months of age. Wkly Epidem Rec 2:8–9

    Google Scholar 

  9. Garenne M ,Leroy O, Beau JP ,Sene I (1991) Child mortality after high titre measles vaccine: Prospective study in Senegal. Lancet 338: 903–907

    Article  PubMed  CAS  Google Scholar 

  10. Orenstein W (1992) World conference on poliomyelitis and measles. New Delhi, January 7–12, 1992

    Google Scholar 

  11. Mast EE, Berg JL, Hanrahan LP, Wassel JT, Davis JP (1990) Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA 264(19): 2529–2533

    Article  PubMed  CAS  Google Scholar 

  12. Centers for Disease Control (1990) Reported cases of measles by state. United States ,weeks 1417. MMWR 39:300

    Google Scholar 

  13. Kurstak E (1993) World conference on poliomyelitis and measles: Vaccines and immunization. Vaccine 11(1): 93–95

    Article  PubMed  CAS  Google Scholar 

  14. Plotkin SA (1992) World conference on poliomyelitis and measles. New Delhi ,January 7–12 ,1992

    Google Scholar 

  15. Taylor J ,Weinberg R ,Tartaglia J, Richardson C, Alkhatib G ,Briedis D ,Appel M ,Norton E ,Paoletti E (1992) Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 187: 321–328

    Article  PubMed  CAS  Google Scholar 

  16. Ajjan N ,Saliou P (1992) World conference on poliomyelitis and measles. New Delhi ,January 7–12 ,1992

    Google Scholar 

  17. WHO (1992) Meningitis associated with measles-mumps-rubella vaccines. Wkly Epidem Rec 67(41): 301–302

    Google Scholar 

  18. Patriarca PA ,Wright PF ,John TJ (1991) Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries. Rev Infect Dis 13: 926–939

    Article  PubMed  CAS  Google Scholar 

  19. Wright PF ,Robert J ,Kim-Farley RJ ,De Quadros CA ,Robertson SE ,Scott RMcN ,Ward NA ,Henderson RH (1991) Strategies for the global eradication of poliomyelitis by the year 2000. N Eng J Med 325(25): 1774–1779

    Article  CAS  Google Scholar 

  20. de Quadros CA ,Andrus SK ,Olive SM ,de Macedo CG ,Henderson DA (1992) Polio eradication from the Western Hemisphere. Ann Rev Public Health 13: 239–252

    Article  Google Scholar 

  21. Ward NA ,Kim-Farley RJ ,Milstein JB ,Hull HF ,Tarel C ,de Quadros C (1992) Poliomyelitis eradication. The Expanded Programme on Immunization of the World Health Organization. In: Kurstak E (ed) Control of Virus Diseases ,Sec. Edition ,Dekker ,New York ,p 247–266

    Google Scholar 

  22. World Health Assembly (1988) Global eradication of poliomyelitis by the year 2000. Resolution WHA 41.28 ,Geneva

    Google Scholar 

  23. Kew O ,De L ,Yong CF ,Nottay B ,Pallansch M ,da Silvia E (1992) The role of virologic surveillance in the global initiative to eradicate poliomyelitis. In: Kurstak E (ed) Control of Virus Diseases ,Sec. Edition ,215-246 ,Dekker ,New York ,p 215–246

    Google Scholar 

  24. Faden H ,Modlin SF ,Thomas ML ,McBean AM ,Ferdon MB ,Ogra PL (1989) Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses. J Infect Dis 162: 1291–1297

    Article  Google Scholar 

  25. Marcuse EK (1989) Why Wait for DTP-E-IPV? Am J Dis Children 143: 1006–1007

    CAS  Google Scholar 

  26. MelnickJL (1992) Poliomyelitis: Eradication in sight. Epidemiol Infect 108: 1–18

    Article  PubMed  CAS  Google Scholar 

  27. John TJ ,Moore R ,Gibson JJ (1992) Choice between inactivated and oral poliovirus vaccine in India. Lancet 339: 504

    Article  PubMed  CAS  Google Scholar 

  28. Hovi T ,Huovilainen A ,Kuronen T (1986) Outbreak of paralytic poliomelitis in Finland: Widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet i: 1427–1435

    Article  Google Scholar 

  29. Sutter RW ,Patriarca PA ,Brogan S (1991) Outbreak of paralytic poliomyelitis in Oman: Evidence for widespread transmission among fully vaccinated children. Lancet 338:715–720

    Article  PubMed  CAS  Google Scholar 

  30. Kohara M ,Abe S ,Komatsu T ,Tago K ,Arita M ,Nomoto A (1988) A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol 62: 2828–2835

    PubMed  CAS  Google Scholar 

  31. WHO (1990) Potential use of new poliovirus vaccine. Bull World Health Organ 68: 545–548

    Google Scholar 

Download references

Authors
  1. Edouard Kurstak
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Faculty of Medicine, University of Montreal, Montreal, Canada

    Edouard Kurstak (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization) (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization)

  2. International Comparative Virology Organization, Montreal, Canada

    Edouard Kurstak (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization) (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization)

  3. Medical Research Centre, King Fahad Hospital, Riyadh, Saudi Arabia

    Edouard Kurstak (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization) (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization)

  4. Viral Diseases Panel, World Health Organization, Geneva, Switzerland

    Edouard Kurstak (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization) (President - International Comparative Virology Organization, Member - Viral Diseases Panel, World Health Organization)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag/Wien

About this chapter

Cite this chapter

Kurstak, E. (1993). Editor’s introduction. In: Kurstak, E. (eds) Measles and Poliomyelitis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9278-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9278-8_1

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82436-8

  • Online ISBN: 978-3-7091-9278-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation